Dicerna, an RNAi drug startup based in Boston (see related story, this issue), has appointed Roberto Guerciolini as senior vice president of pharmaceutical development.
Guerciolini, who is also a co-founder of Dicerna, was previously the senior vice president of development and chief medical officer of Sirna Therapeutics.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
